EurekaMag.com logo
+ Site Statistics
References:
47,893,527
Abstracts:
28,296,643
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Antiemetic efficacy of high-dose metoclopramide and dexamethasone in patients receiving cisplatin chemotherapy: a randomized trial






Oncology 49(6): 479-483

Antiemetic efficacy of high-dose metoclopramide and dexamethasone in patients receiving cisplatin chemotherapy: a randomized trial

In a prospective randomized trial we compared the antiemetic efficacy of metoclopramide (MCP) and dexamethasone (DXM). A total of 172 patients receiving chemotherapy based on cisplatin 100 mg/m2/day were randomly allocated to four groups. CP was administered in 5 doses of 1.5 mg/kg (group A), 2 mg/kg (group C), or combined with 4 doses of DXM 4 mg/6 h (MCP: 1.5 mg/kg in group B; 2 mg/kg in group D). Vomiting was decreased in the DXM groups compared to groups A and C (p < 0.002), and the duration of nausea was greater in group A than in group D (P < 0.004). A greater disturbance in appetite was observed in group A compared to groups B (p < 0.028), D(p < 0.001) and C (p < 0.045). Activity problems were greater in group A than in C (p < 0.003) and D(p < 0.005). We noticed that a small increase in MCP (0.5 mg/kg) did not influence the antiemetic effect. The addition of DXM did not significantly alter the antiemetic results at the lower MCP dose, but improved them when MCP was slightly increased. We conclude that DXM slightly improves the antiemetic effect of MCP and the effects are related to the MCP dose.


Accession: 009770450

PMID: 1465288



Related references

Shinkai, T.; Saijo, N.; Eguchi, K.; Sasaki, Y.; Tamura, T.; Tominaga, K.; Sakurai, M.; Sano, T.; Taito, H.; Takahashi, H., 1986: Antiemetic efficacy of high-dose intravenous metoclopramide and dexamethasone in patients receiving cisplatin-based chemotherapy: a randomized controlled trial. High-dose intravenous (IV) metoclopramide has shown efficacy with few side effects for the treatment of nausea and vomiting on the day of cisplatin administration. From November 1984 to January 1986, two randomized trials in an antiemetic study we...

Ichiki, M.; Sakurai, M.; Karato, A.; Hayashi, I., 1996: Antiemetic efficacy of granisetron compared with high-dose metoclopramide plus dexamethasone in patients with primary lung cancer receiving chemotherapy: A randomized crossover trial. This clinical trial was carried out to evaluate the efficacy and safety of granisetron compared with high-dose metoclopramide plus dexamethasone in preventing nausea and vomiting induced by the regimen composed of cisplatin, carboplatin and etopos...

D'olimpio, J.T.; Camacho, F.; Chandra, P.; Lesser, M.; Maldonado, M.; Wollner, D.; Wiernik, P.H., 1985: Antiemetic efficacy of high dose dexamethasone vs. placebo in patients receiving cisplatin based chemotherapy a randomized double blind controlled clinical trial. The antiemetic effect of short courses of high-dose dexamethasone was compared with that of placebo in 64 patients receiving cisplatin-based cancer chemotherapy, in a double-blind randomized clinical trial. All patients were receiving cisplatin fo...

Chua, D.T.; Sham, J.S.; Au, G.K.; Choy, D.; Kwong, D.L.; Yau, C.C.; Cheng, A.C., 1996: The antiemetic efficacy of tropisetron plus dexamethasone as compared with conventional metoclopramide-dexamethasone combination in Orientals receiving cisplatin chemotherapy: a randomized crossover trial. 1. We report a single-blind randomized crossover trial comparing the efficacy of tropisetron plus dexamethasone (TROPDEX) vs conventional combination of metoclopramide, dexamethasone and diphenhydramine (METDEX) in prevention of acute and delayed...

Chua, D.T.T.; Sham, J.S.T.; Au, G.K.H.; Choy, D.; Kwong, D.L.W.; Yau, C.C.; Cheng, A.C.K., 1996: The antiemetic efficacy of tropisetron plus dexamethasone as compared with conventional metoclopramide-dexamethasone combination in Orientals receiving cisplatin chemotherapy: A randomized crossover trial. 1. We report a single-blind randomized crossover trial comparing the efficacy of tropisetron plus dexamethasone (TROPDEX) vs conventional combination of metoclopramide, dexamethasone and diphenhydramine (METDEX) in prevention of acute and delayed...

D'Olimpio, J.T.; Camacho, F.; Chandra, P.; Lesser, M.; Maldonado, M.; Wollner, D.; Wiernik, P.H., 1985: Antiemetic efficacy of high-dose dexamethasone versus placebo in patients receiving cisplatin-based chemotherapy: a randomized double-blind controlled clinical trial. The antiemetic effect of short courses of high-dose dexamethasone was compared with that of placebo in 64 patients receiving cisplatin-based cancer chemotherapy, in a double-blind randomized clinical trial. All patients were receiving cisplatin fo...

Ibrahim, E.M.; Al-Idrissi, H.Y.; Ibrahim, A.; Absood, G.; Al-Dossary, E.; Al-Jammaa, A.; Al-Ethan, S.; Eliopoulos, A., 1986: Antiemetic efficacy of high-dose dexamethasone: randomized, double-blind, crossover study with high-dose metoclopramide in patients receiving cancer chemotherapy. A double-blind, randomized, crossover study was conducted to compare the efficacy and safety of high-dose dexamethasone and high-dose metoclopramide in the treatment of chemotherapy-induced nausea and vomiting. All entered patients had no prior ch...

Ithimakin, S.; Runglodvatana, K.; Nimmannit, A.; Akewanlop, C.; Srimuninnimit, V.; Keerativitayanan, N.; Soparattanapaisarn, N.; Laocharoenkeat, A., 2012: Randomized, double-blinded, placebo-controlled trial of ondansetron plus dexamethasone with or without metoclopramide as antiemetic prophylaxis in patients receiving high-dose cisplatin in medical practice. Ondansetron plus dexamethasone are standard antiemetic agents for highly emetogenic chemotherapy. Metoclopramide is a dopamine antagonist, which may enhance efficacy of ondansetron and dexamethasone. The objective of this study was to assess the e...

González Barón, M.; Chacón, J.I.; García Girón, C.; Ordóñez Gallego, A.; García de Paredes, M.L.; Feliu, J.; Zamora, P.; Herranz, C.; Garrido, P.; Artal, A., 1991: Antiemetic regimens in outpatients receiving cisplatin and non-cisplatin chemotherapy. A randomized trial comparing high-dose metoclopramide plus methylprednisolone with and without lorazepam. Results of a randomized trial on antiemesis for cisplatin (CDDP) and non-CDDP chemotherapy-induced vomiting are reported. One hundred and sixty-three outpatients received 282 chemotherapy courses (141 with CDDP and 141 without CDDP). Patients were...

Kris M.; Clark R.; Gralla R.; Tyson L.; O'hehir M., 1986: Randomized double blind antiemetic trial comparing combinations of metoclopramide dexamethasone and lorazepam with metoclopramide dexamethasone and diphenhydramine in 120 patients receiving cisplatin. Proceedings American Society of Clinical Oncology Annual Meeting 5: 261